An automated HIV-1 Env-pseudotyped virus production for global HIV vaccine trials.

BACKGROUND: Infections with HIV still represent a major human health problem worldwide and a vaccine is the only long-term option to fight efficiently against this virus. Standardized assessments of HIV-specific immune responses in vaccine trials are essential for prioritizing vaccine candidates in...

Full description

Bibliographic Details
Main Authors: Anke Schultz, Stefanie Koch, Martina Fuss, Angela S Mazzotta, Marcella Sarzotti-Kelsoe, Daniel A Ozaki, David C Montefiori, Hagen von Briesen, Heiko Zimmermann, Andreas Meyerhans
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3531445?pdf=render